Physician profile
Michael A Morse
NPI 1922285337
$353,088.91
in general payments reported to CMS, 2019-2025
18 companies · $46K in 2025
The $46K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $32K · 2021: $83K · 2022: $47K · 2023: $68K · 2024: $40K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $116K · Travel and Lodging: $17K · Food and Beverage: $8,895 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,000 · Grant: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $115,675.00 |
| Travel and Lodging | $16,627.69 |
| Food and Beverage | $8,895.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,000.00 |
| Grant | $222.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $197,884.38 | 2019-2025 | Mitraclip, Epic, Navitor |
| Edwards Lifesciences Corporation | $134,546.53 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $12,025.90 | 2019-2025 | Watchman Access System, General - Stents, Watchman Flx |
| Livanova USA, INC. | $3,296.60 | 2019 | |
| Medtronic, INC. | $1,981.86 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Ancora Heart, INC. | $1,800.63 | 2023 | Accucinch |
| Inari Medical, INC. | $585.88 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $297.54 | 2019-2021 | |
| Heartflow, INC. | $236.19 | 2024-2025 | |
| Philips North America LLC | $108.23 | 2024 | (9148) Ice 3d |
| Angiodynamics, INC. | $69.66 | 2020-2025 | Alphavac |
| Amgen INC. | $68.42 | 2023-2024 | Repatha |
| Atricure, INC. | $58.63 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $41.73 | 2024-2025 | |
| Medtronic Vascular, INC. | $40.04 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $16.25 | 2024 | Arcalyst |
| Terumo Medical Corporation | $15.63 | 2023 | Glidewire, Angio-Seal |
| Saranas, INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.